Merrimack Pharmaceuticals
MACK
$14.98
Share price
1.63%
Change (1 day)
18.98%
Change (1 year)
Categories
Merrimack Pharmaceuticals (MACK) - Net assets
Net assets on the balance sheet as of December 2023 : $18.74 M
According to Merrimack Pharmaceuticals's latest financial reports the company has $18.74 M in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Merrimack Pharmaceuticals - Net assets on balance sheet (from 2010 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2023-12-31 | $18.74 M | -2.6% |
| 2022-12-31 | $19.24 M | 35.67% |
| 2021-12-31 | $14.18 M | -11.36% |
| 2020-12-31 | $16 M | -7.54% |
| 2019-12-31 | $17.31 M | -70.57% |
| 2018-12-31 | $58.81 M | -38.91% |
| 2017-12-31 | $96.28 M | -138.11% |
| 2016-12-31 | $-0.26 B | 37.55% |
| 2015-12-31 | $-0.19 B | 79.96% |
| 2014-12-31 | $-0.11 B | 136.67% |
| 2013-12-31 | $-43.13 M | 571.78% |
| 2012-12-31 | $-6.42 M | -70.4% |
| 2011-12-31 | $-21.7 M | -90.09% |
| 2010-12-31 | $-0.22 B | 14.77% |
| 2009-12-31 | $-0.2 B |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Sanofi SNY | $82.20 B | 438,388.29% | 🇫🇷 France |
 Geron GERN | $0.24 B | 1,222.61% | 🇺🇸 USA |
 Clovis Oncology CLVS | -$0.42 B | -2,329.08% | 🇺🇸 USA |
 AVEO Oncology
AVEO | $28.84 M | 53.86% | 🇺🇸 USA |
 Eterna Therapeutics ERNA | $2.23 M | -88.09% | 🇺🇸 USA |